HEOR

Meet Hamzah Aideed, Associate Director, Global Market Access at HEOR!   Hamzah has over 13 years of experience in healthcare and life sciences consulting, with expertise spanning: - Market opportunity assessment and forecasting - Access and policy landscape evaluations - Payer research - Pricing strategy - Reimbursement planning Hamzah has worked extensively across key therapeutic areas such as oncology, immunology, and diabetes, partnering with leading pharma and biotech clients to support strategic decision-making and deliver evidence-based solutions across the product lifecycle.   Connect with Hamzah and the team to discuss your market access challenges and explore solutions to optimise the value of your intervention – contact us to arrange a chat, virtually or at #ISPOREurope. #heor #healtheconomics #marketaccess

HEOR is excited to attend the International Consortium on Newborn Sequencing (ICoNS) 2025 conference in London on October 23–24!   Our rare disease specialist, Jenny Lee, will be joining peers from across the healthcare ecosystem to explore the latest breakthroughs in genomics and rare disease identification in newborns. She’ll be attending key sessions and connecting with the community to explore how innovation in genomics is shaping the future of early-life care.   Contact us if you’re attending #ICoNS25 and would like to connect with Jenny.   #newbornsequencing #genomics #heor #raredisease #healthcareinnovation 

HEOR will be exhibiting and presenting at the World Orphan Drug Congress Europe.   Jenny Lee, Principal Consultant at HEOR, will co-present with Miranda Bailey, Associate Vice President, HEOR & Pricing at Rocket Pharmaceuticals, on the importance of thought partnership in navigating the rare disease landscape…   “In a world where HEOR must tackle complex, multidisciplinary challenges with limited resources, strategic thought partnership helps teams stay lean, focused, and equipped to deliver impactful orphan technology programs.”   Learn more about their session: https://lnkd.in/exgkiD9t   Jen will also be joined by another rare disease expert from HEOR, Ewa Stawowczyk, at our booth (10.111) – they look forward to connecting with the community.   Terrapinn #raredisease #heor

We’re thrilled to be part of the IF Oxford - Oxford Science & Ideas Festival this Halloween, where we’ll showcase our fascinating work on how disease impacts healthcare systems… zombie-style! Join HEOR CEO, Phil McEwan, and colleagues on the 31 October for a light-hearted and interactive session exploring what zombies can teach us about public health. From fast-moving infected to slow shamblers, we’ll compare zombie types across fictional universes to reveal how medical professionals tackle real-world health challenges and how modelling helps us understand and solve complex health issues. Whether you're a science enthusiast, curious about health economics, or just love zombies, this session is for you! Learn more here: https://lnkd.in/eK7pWZrb #IFOx2025 #HEOR #publichealth #healtheconomics

HEOR has joined EMIG - Ethical Medicines Industry Group! We are looking forward to participating in discussions on the NHS 10-Year Plan and the health system expert panel at the upcoming meeting. We recently shared our perspective on the NHS 10-Year Plan, exploring whether AI could be part of the solution to the challenges facing the health service. If you missed it, you can read it here in The BMJ: https://lnkd.in/edTwNc-8. #NHSplan #healthcareinnovation

When preparing for a NICE single technology appraisal (STA), UK clients often rely on systematic literature reviews (SLRs) developed by global teams. While these reviews are comprehensive, they’re not always tailored to the specific requirements of the UK health technology assessment (HTA) landscape. NICE submissions demand a more focused approach – one that addresses the UK-specific decision problem and adheres to NICE-recommended methodologies. At HEOR, our evidence review and synthesis team specialises in critically evaluating global SLRs for UK HTA submissions, bringing deep insight into what NICE expects. They provide early strategic recommendations that inform the final stages of evidence synthesis. This proactive approach helps ensure that the evidence package is robust, relevant, and ready for submission. Learn more about this process: https://lnkd.in/ecAKg7Ar #heor #literaturereview #hta NICE - National Institute for Health and Care Excellence Kevin Cadwell Cassandra Springate Patrice Carter Shelley de Kock

Meet Jo Welton, Senior Medical Writer, who shares her experience working at HEOR, describing a culture we're truly proud of – “inclusive, supportive, collaborative, and non-political”. Jo also summarises one of our core services: “We help our clients communicate complex information in a way that is engaging and informative for their target audience, with the ultimate goal of helping people with a wide array of conditions gain access to, and benefit from, new and innovative treatments.” If you’re passionate about making a real impact and want to be part of a company that empowers both its people and clients, we’d love to hear from you. Visit our website to explore current vacancies and read Jo’s life at HEOR interview in full: https://lnkd.in/eWRy2fbv. #lifeatheor #heor

AI can help you write a CV, but it’s the human touch that gets it noticed. In a world where many applications are starting to look the same, Marie (Cuddon) Luker, Head of Talent Acquisition, reminds us why authenticity still matters.   Every application to HEOR is reviewed by a person and we are looking for a spark that sets someone apart – authentic and genuine motivation and potential to thrive within our people-first culture.    Marie's insightful article offers practical advice for candidates on how to use AI as a support, not a substitute, and how to stand out in a crowded job market. If you're thinking about your next move, this is a must-read and you'll (re) discover how to let your personality shine in your application.   Read in full: https://lnkd.in/eUMeRVvH #AIinRecruitment #CareerAdvice #TalentAcquisition #ScienceCareers

Behind every literature review, economic model, and value communication material lies a comprehensive and crucial process: the search for information, and at the heart of the process is the information scientist.   We explore the work of HEOR’s principal information scientist, Shelley de Kock, an integral member of the evidence review and synthesis team who design and execute bespoke search strategies that uncover the critical evidence underpinning all our client work.   Learn about: • Industry-accepted, user-friendly, and time-efficient citation tools that are used in cases when identifying the right evidence is challenging, i.e., when concepts – like “burden” or “unmet need” – aren’t always explicitly defined in the literature • The limitations and benefits of AI tools such as Semantic Scholar • Literature surveillance, a proactive approach that ensures new evidence is integrated into systematic reviews as it emerges, and so much more! https://lnkd.in/eKGg92Gq #literaturereview #informationscience #heor #healtheconomics

Meet Marilena Appierto, Principal Medical Writer, who shares her experience working at HEOR, describing the key to success within the value communications team:   “I think what really differentiates our team is that we are not just effective communicators, we’re also great listeners. Whenever approaching a new project, we seek to understand the needs and challenges of our clients and build a partnership based on clear communication and trust. This allows us to design effective and efficient solutions that truly support their strategic goals.”   Read the full #lifeatheor interview: https://lnkd.in/ehn7q6tc   #heor #hta #medicalwriting